Evidence map›Paper›PMID 18007387›Full record

ArticleMolecules (Basel, Switzerland)2005

Synthesis, tautomeric states and crystal structure of (Z)-ethyl 2-cyano-2-(3H-quinazoline-4-ylidene) acetate and (Z)-ethyl 2-cyano-2-(2-methyl-3H-quinazoline-4-ylidene) acetate.

Muborak Tulyasheva, Bakhtiyor F Rasulev, Akmal G Tojiboev, Kambarali K Turgunov, Bakhodir Tashkhodjaev, Nasrulla D Abdullaev, Khusnutdin M Shakhidoyatov

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Muborak TulyashevaInstitute of the Chemistry of Plant Substances AS RUz, Uzbekistan. tulyasheva@yahoo.com
Bakhtiyor F Rasulev
Akmal G Tojiboev
Kambarali K Turgunov
Bakhodir Tashkhodjaev
Nasrulla D Abdullaev
Khusnutdin M Shakhidoyatov

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new compounds (Z)-ethyl 2-cyano-2-(3H- and 2-methyl-3H-quinazoline-4-ylidene) acetate (1 and 2, respectively) were synthesized by multi-step reactions. The structures in a solution have been determined by (1)H-NMR spectroscopy and in the crystal form by X-ray analysis. Molecule 1 crystallized in a primitive monoclinic cell, space group capital ER, P2(1/c). The cell dimensions are a=7.970(6) A, b=7.061(2) A, c=20.537(7) A, beta=97.69(5) degrees , V=1145.3(10) A(3). Molecule 2 crystallized in a triclinic cell, space group P-1, the cell dimensions are a=8.196(5) A, b=8.997(6) A, c=9.435(4) A, alpha=74.22(4) degrees, beta=89.75(4) degrees , gamma=74.07(5) degrees , V=641.9(6) A(3). In both compounds the presence of intra-molecular NH---O=C hydrogen bonding between the nitrogen atom in position 3 of the quinazoline ring and a carbonyl group of the ethyl cyanoacetate residue was proven by quantum-chemical, (1)H-NMR and X-ray methods.

Indexed as

AcetatesCrystallography, X-RayHydrogen BondingMagnetic Resonance SpectroscopyModels, MolecularQuinazolinesStereoisomerismThermodynamicsAcetatesQuinazolines(Z)-ethyl 2-cyano-2-(2-methyl-3H-quinazoline-4-ylidene) acetate(Z)-ethyl 2-cyano-2-(3H-quinazoline-4-ylidene) acetate

Identifiers

PMID18007387
PMCPMC6147644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.